BioCryst Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 96   

Articles published

BCRX 10.23 +0.20 (1.99%)
price chart
BioCryst Pharmaceuticals, Inc. Short Interest Update
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), A reduction of 393,718 shares or 4.2% was observed in the short interest of BioCryst Pharmaceuticals, Inc. The interest on November 13,2015 came in at 9,081,465 shares and as per the average daily trading ...
A Reversal for BioCryst Pharmaceuticals, Inc. Is Not Near. The Stock ...  Voice Chronicle
Top Stories: BioCryst Pharmaceuticals (NASDAQ:BCRX), First Northwest Bancorp ...  Benchmark Monitor
Company Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Rally 4.26%
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) rose by 4.26% in the past week and 14.11% for the last 4 weeks.
Here's Why Shares of BioCryst Pharmaceuticals, Inc. Are Falling Today
What: Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX), a biotech company that specializes in the development of small molecular drugs, sank by over 20% today on heavy volume.
BioCryst Pharmaceuticals (BCRX) Stock Drops Despite Positive Drug Trial Results
3 Biotech Stocks Are Getting Crushed: BioCryst Pharmaceuticals, Inc. (NASDAQ ...  Wall Street Point
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) Stock Price Up as Sentiment Improves
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) hedge funds sentiment increased to 2.29 in Q2 2015. Its up 0.94, from 1.35 in 2015Q1.
Durham's BioCryst cuts $45 million deal with Australian firm
Durham-based BioCryst Pharmaceuticals, Inc., (Nasdaq: BCRX) licensed its recently approved flu treatment Rapivap in a deal that could bring the company $45 million plus sales royalties.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has licensed RAPIVAB (peramivir ...  Inside Trade
BioCryst Pharma licenses flu med to CSL Limited (BCRX)  Seeking Alpha
Technical and Fundamental Report on BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) (TREND ANALYSIS) shares were traded with thin volume. The stock closed last trading session at $9.47, down by -7.25%, with a volume of 858,732 shares against an average volume for the last 3 months of ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Short Interest Update  News Watch International
BioCryst Pharma (BCRX) is Downgraded by BofA/Merrill to Underperform  Money Flow Index
BioCryst Pharmaceuticals, Inc. Analyst Rating Update
Analysts at Zacks have given a short term rating of hold on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) with a rank of 3. The company has received an average rating of 1.75 from 8 brokerage firms.
NASDAQ:BCRX Stockholder Notice: Investigation of BioCryst Pharmaceuticals ...  Empowered News
Biocryst Pharmaceuticals Incorporated (NASDAQ:BCRX): Can Biocryst ...  The Bulletin
Revenue Update on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) announced the earnings results for Fiscal Year 2015 and Q3. The results came in during Pre-market on Nov 5, 2015.
BioCryst Pharma (BCRX) Announces Quarterly Earnings Results, Reports EPS of ...  Money Flow Index
BioCryst Pharmaceuticals (BCRX) Scheduled to Post Earnings on Thursday  Dakota Financial News
Momentum Stock in Focus - BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
According to Zacks, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has been given a high momentum style score. The score calculation is based on a number of factors indicating that the stock might be at a favorable level to enter a position based on the ...
BioCryst Pharmaceuticals, Inc. Price Target Update  American Trade Journal
BioCryst Pharmaceuticals Earns Market Perform Rating from Oppenheimer (BCRX)  WKRB News
Company Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Rally 5.02%
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) rose by 5.02% in the past week and 8.82% for the last 4 weeks.
Market Movers: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Sientra, Inc ...  Benchmark Monitor
BioCryst Pharmaceuticals Cut to "Underperform" at Bank of America ...  STORM